EyePoint Pharmaceuticals, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
480 Pleasant Street, Suite B300, Watertown, MA

Insiders trading volume in the past year

EyePoint Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $103M +$37.6M +57.6% May 6, 2024
EW Healthcare Partners, L.P. Other*, 10%+ Owner $87.3M Sep 1, 2023
Ye Liu Director $2.51M -$37.2M -93.7% Jan 11, 2024
Therapeutics Ocumension Director $2.51M -$37.2M -93.7% Jan 11, 2024
Nancy Lurker Director $2M -$849K -29.8% Aug 16, 2024
David Scott Jones SVP & Chief Commercial Officer $1.44M -$1.76M -55% Feb 9, 2024
Dario A. Paggiarino Chief Medical Officer $1.39M -$2.17M -61.1% Mar 30, 2024
Michael Craig Pine Chief Corp Dev.&Strat. Officer $965K Jan 5, 2024
Jay S. Duker President and CEO, Director $816K Jul 10, 2024
George Elston Chief Financial Officer $720K May 25, 2024
John B. Landis Director $204K Jan 5, 2024
Douglas Godshall Director $201K Jun 22, 2021
Karen L. Zaderej Director $152K +$99.8K +190% Aug 19, 2024
Goran Ando Director $105K +$39.8K +61.3% Aug 21, 2024
Wendy F. Dicicco Director $77.6K +$20K +34.7% Aug 20, 2024
Anthony P. Adamis Director $61.8K Jun 23, 2024
David R. Guyer Director $18.6K -$384K -95.4% Jul 12, 2024
Ramiro Ribeiro Chief Medical Officer Mar 1, 2024
Stuart Duty Director Jan 5, 2024
Adage Capital Management, L.P. 10%+ Owner Apr 18, 2024
Fred Hassan Director Sep 3, 2024

Recent Insider Transactions by Companies or Individuals for EyePoint Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.